COMMENTING INSTRUCTIONS

To comment to a blog article, select the comment icon at the bottom of the article. Then, simply enter your information and comment in the appropriate fields. Finally, select the "create post" button and follow the anti-spam instructions.

Please do not comment by linking to an external response. This will be added as a reference and mistakenly appear as something the article author submitted.

Blog Index
The journal that this archive was targeting has been deleted. Please update your configuration.
Wednesday
Jul022014

SRS members are invited to submit nominations for 2015 SRS elections

On behalf of the Society of Radiopharmaceutical Sciences (SRS), we would like to announce the call for nominations for the 2015 SRS elections. We are accepting nominations for the following Officer and Board Member positions. 

  • President- Elect (two year term). The President-Elect will be an SRS member from Asia/Oceania for the 2015-2017 term of office. 
  • Three (3) Board Members: One from each global region – The Americas, Europe and Asia/Oceania (six-year terms)

Elected individuals will begin his/her terms at the SRS Business Meeting that will be held during the 21st International Symposium on Radiopharmaceutical Sciences (May 26-31, 2015 in Columbia, Missouri, USA). We ask you to remember that as an SRS Officer or Board member, nominees will be expected to devote significant personal time and energy to provide the SRS critical leadership in maintaining and enhancing the Society in service to its members,  advancing radiopharmaceutical sciences at the international level, and should attend all SRS conferences and meetings. Nominations should be sent to any one of the current members of the SRS Officers or Board of Directors for recommendation, who in turn will forward them to the SRS Nominating Committee. 

Nominations should be submitted by August 4, 2014. The names and contact information of the SRS Officers and Board of Directors are found at http://www.srsweb.org/about/.

Your assistance in helping the SRS identify effective future leadership is important.

Wednesday
Sep182013

President-Elect, Henry VanBrocklin invites your input

Henry VanBrocklin, PhD, SRS President-ElectDear Friends and Colleagues,

As I commence my commitment as a leader within the SRS, I would like to take this opportunity to thank you for your support during the election and to all those who accepted nominations to run for office. The continued success of our organization relies on the volunteers who agree to serve. I appreciate your confidence in my abilities to guide SRS and look forward to working with the board and membership over the next several years.

With the successful conclusion of the 20th ISRS on Jeju, I congratulate the Organizing Committee for a wonderful meeting highlighting the latest innovative chemistry and instrumentation research. We look forward to the 2015 meeting in Columbia, Missouri USA and the 2017 meeting in Dresden, Germany.

As we enter the Fall season, it is time for us to renew our membership in SRS. Keep your member benefits active by completing your annual renewal. Your support enables the development of society education programs and provides students the opportunity to attend the biennial meetings. These important programs support the future generation of radiopharmaceutical scientists, keeping our society vital.

Again, I look forward to working with you over the next four years to strengthen our society. I ask that you contact me by email [henry.vanbrocklin(at)ucsf.edu] with any thoughts and ideas that you may have to improve the quality of our meetings, enhance our educational programs and membership offerings.

Respectfully Yours,

Henry VanBrocklin

 

Monday
Aug262013

Post-Doctoral Fellowship Opportunity

Eyal Mishani, PhD, Hadassah Medical OrganizationHADASSAH MEDICAL ORGANIZATION
HADASSAH EIN KEREM
CYCLOTRON RADIOCHEMISTRY FACILITY

Post-Doctoral Fellowship in Radiochemistry

Dear Fellow,

We, at the Cyclotron/Radiochemistry Facility at the Hadassah University Hospital in Jerusalem, Israel, are looking for a post-doctoral fellow in radiochemistry for a period of 2-3 years. If you have an interest in this position or are acquainted with someone who has a broad-based experience in fluorine-18 and carbon-11 chemistry and automation, please contact me via email. The post-doctoral fellow will be mainly involved in two projects, including (i) development of fluorine-18 labeled ammonium salt derivatives for myocardial perfusion PET-imaging, and (ii) carbon-11, fluorine-18 and iodine-124 labeling of low-MW tyrosine kinase inhibitors (TKIs) for PET imaging of EGFR-positive tumors in oncology. The selected candidate will be granted full scholarship.

The Cyclotron Radiochemistry facility at Hadassah hospital operates two cyclotrons, a small animal-dedicated PET/ CT, and fully equipped radiochemistry and pre-clinical laboratories enabling the production and research of various radiolabeled compounds. The facility personnel includes permanent experienced engineers, chemists and biologists who will support and assist any activity carried out by the selected postdoc candidate.

For further information and submission of CV, please contact Prof. Eyal Mishani at mishani (at) ekmd.huji.ac.il

 

Wednesday
Jul242013

The SRS community has lost a long-time colleague and friend

Dirk Roeda, 3-4-1951 - 19-7-2013Dr. Dirk Roeda, of Service Hospitalier Frédéric Joliot, passed away on July 19.

Dirk Roeda was born in 1951, April 3rd, in Weesp, The Netherlands. He studied organic chemistry at the Vrije Universiteit of Amsterdam with Pr. Fritz Bickelhaupt and subsequently completed a PhD thesis on the radiosynthesis and application in radiopharmaceutical chemistry of carbon-11-labelled phosgene at the same university (1982). This work was in part carried out at the Service Hospitalier Frédéric Joliot (CEA) in Orsay, France (Dr. Dominique Comar).

Dr. Roeda then moved to Turku (Finland) to join the Turku Medical Cyclotron Project of the University of Turku and Åbo Akademi, the infant stage of today's national Turku PET Centre, to contribute to the further development of the radiochemistry activities there. 

In 1986, he joined the medical physics department of the University of Aberdeen (Scotland) under Prof. John Mallard to participate in the setup of a PET chemistry laboratory from scratch, including the installation of a second-hand CS30 cyclotron.

In 1993, Dr. Roeda returned to Orsay (France) to join Dr. Christian Crouzel's radiochemistry group at the Service Hospitalier Frédéric Joliot, where he pursued his research interests on the development of methodologies in carbon-11 and fluorine-18 chemistry, notably the synthesis and application of carbon-11-labeled one-carbon synthons like formaldehyde, formic acid, formyl chloride, carbon monoxide and phosgene as well as the exploration of novel routes of radiofluorination. 

Friday
Jul052013

Reflections and Expectations

SRS Immediate Past President, Yasuhisa Fujibayashi

It is surprising for me that my two-year term as President of the Society of Radiopharmaceutical Sciences has come to the end. Dr. Albert D. Windhorst, Head of Radiopharmaceutical Chemistry, VU University Medical Centre, Amsterdam Netherlands, has begun his term as the new SRS President. Dr. Windhorst is a young and active researcher and leader in the field, and his ability has already been demonstrated through his role as Chairman of ISRS 2011. I believe that he will bring a breath of fresh air into our Society.

I served as the fourth President following the establishment of the SRS, and it has been a period of stabilization as well as a period of preparation for next steps. Fortunately, our financial condition and member numbers have been healthy during my term. This cannot be realized without the continuous and effective efforts of the Board of Directors, especially SRS Officers: Drs. Wynn Volkert, Albert D. Windhorst, Sally Schwarz and Eyal Mishani. Close cooperation with Mr. Charles Metzger, SRS Executive Director, has been also an essential part of my job. I would like to express my deep appreciation to all of them for their support.

During my term, a new relationship was created between the SRS and Elsevier, publisher of Nuclear Medicine and Biology. This was a big challenge for the Society and involved a contract revision responsive to young, paperless-age members. SRS leadership believe that this renegotiated contract will also positively affect the financial future of the Society.

The establishment of an “Emeritus” category of SRS membership was a response to the maturation of the Society. Members who have accumulated at least five consecutive years of SRS membership and who have fully retired from the field of radiopharmaceutical sciences but who wish to remain members of the SRS may become Emeritus Members.

Now, it is time to make a leap forward. I look forward to working with Dr. Albert Windhorst, the new SRS President, as he leads the Society with a new wisdom, dream and enthusiasm.